OrthoAccel Technologies, Inc. Names Veteran Medtech Executive Mark Steele as Senior Vice President of North America Sales

HOUSTON, Oct. 12, 2016 – OrthoAccel® Technologies, Inc. announces that Mark Steele, a healthcare and medical device sales executive with two decades of experience, has joined the innovation company as senior vice president of North America sales. OrthoAccel manufactures and markets AcceleDent®, the first and only FDA-cleared vibratory device that has been clinically proven to speed up orthodontic treatment by as much as 50 percent and significantly reduce the discomfort associated with treatment. AcceleDent is currently available in more than 3,300 orthodontic locations in North America.

“I’m excited to be a part of such an outstanding company as OrthoAccel,” said Steele, who will lead OrthoAccel’s North American sales division, overseeing all aspects of business development and revenue growth. “I’ve been impressed by the team’s passion to enhance the orthodontic experience for orthodontists and patients through innovative technologies such as AcceleDent.”

Most recently Steele served as executive vice president of sales, marketing and customer service for MSD, a privately owned company that provides medical technologies to alternate site healthcare providers. At MSD, Steele oversaw inside and outside sales teams, generating $250 million in sales to home infusion, home medical equipment and oncology providers. His many accomplishments at MSD include improving the company’s gross margin by instituting profitability strategies as well as launching key marketing programs such as a successful e-commerce site and a consumer-focused retail initiative.

Prior to MSD, Steele had an 18-year career at PSS World Medical, Inc., where he was named president of the company’s extended care business, Gulf South Medical Supply, Inc., after rising through the ranks of sales representative, regional vice president of sales and vice president of marketing for the company’s physician business.

“With his strong track record of success in medical device sales, I am confident Mark will continue advancing AcceleDent as standard of care in the orthodontic industry,” said Michael K. Lowe, president and CEO of OrthoAccel. “OrthoAccel is the leader in accelerated orthodontics and Mark’s focus on strategic results and excellent customer care will ensure we maintain this market leadership.”

Lowe added that AcceleDent is the preferred accelerated orthodontic treatment solution according to orthodontists participating in surveys conducted by Orthotown and the Journal of Clinical Orthodontics.

Orthodontists and staff members interested in learning more information about AcceleDent or contacting a sales representative can visit AcceleDent.com.

About OrthoAccel® Technologies, Inc.
OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the creation, manufacturing, marketing and sales of innovative solutions that enhance dental care and orthodontic treatment. Among the company’s innovations is AcceleDent®, an FDA-cleared, Class II medical device that speeds up orthodontic treatment by as much as 50 percent and reduces discomfort associated with orthodontic treatment when used in conjunction with braces or aligners. OrthoAccel, the Leader in Accelerated Orthodontics, has received positive feedback from patients and leading orthodontists from around the world who recommend the award-winning AcceleDent as the fast, safe and gentle solution to accelerate orthodontic treatment. Ranked on Deloitte’s 2015 Technology Fast 500 as one of the fastest growing companies in North America, OrthoAccel is based in Houston, Texas and maintains a global presence through its EMEA office in Essen, Germany. To learn more about OrthoAccel’s focus on improving the journey to healthy, beautiful smiles, visit AcceleDent.com.

Media Contacts